15 December 2022 - Aotearoa's drug buying agency has announced it will fully fund the EpiPen brand of adrenaline auto-injectors from early 2023 - and one advocacy group says it'll "make a huge difference".
PHARMAC announced the EpiPen will be funded for anyone who has previously experienced severe anaphylaxis or anyone who is at "significant risk".